ES513933A0 - Un procedimiento para la preparacion de un derivado del indol. - Google Patents

Un procedimiento para la preparacion de un derivado del indol.

Info

Publication number
ES513933A0
ES513933A0 ES513933A ES513933A ES513933A0 ES 513933 A0 ES513933 A0 ES 513933A0 ES 513933 A ES513933 A ES 513933A ES 513933 A ES513933 A ES 513933A ES 513933 A0 ES513933 A0 ES 513933A0
Authority
ES
Spain
Prior art keywords
indol
derivative
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513933A
Other languages
English (en)
Other versions
ES8402268A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES513933A0 publication Critical patent/ES513933A0/es
Publication of ES8402268A1 publication Critical patent/ES8402268A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ES513933A 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol. Expired ES8402268A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026286 1980-08-12

Publications (2)

Publication Number Publication Date
ES513933A0 true ES513933A0 (es) 1984-01-16
ES8402268A1 ES8402268A1 (es) 1984-01-16

Family

ID=10515410

Family Applications (5)

Application Number Title Priority Date Filing Date
ES504693A Expired ES8301210A1 (es) 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol.
ES513933A Expired ES8402268A1 (es) 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol.
ES520785A Granted ES520785A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520783A Expired ES8504706A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520784A Expired ES8500902A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES504693A Expired ES8301210A1 (es) 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES520785A Granted ES520785A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520783A Expired ES8504706A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520784A Expired ES8500902A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Country Status (16)

Country Link
US (1) US4650810A (es)
JP (1) JPS5764669A (es)
AU (1) AU548467B2 (es)
BE (1) BE889929A (es)
CA (1) CA1169428A (es)
CH (1) CH651551A5 (es)
DE (1) DE3131728A1 (es)
DK (1) DK157920C (es)
ES (5) ES8301210A1 (es)
FR (1) FR2488607A1 (es)
IE (1) IE51491B1 (es)
IT (1) IT1171449B (es)
NL (1) NL8103769A (es)
NZ (1) NZ197996A (es)
SE (1) SE454880B (es)
ZA (1) ZA815540B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
SI21560B (sl) * 1990-06-07 2005-04-30 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
US5254383A (en) * 1992-09-14 1993-10-19 Allied-Signal Inc. Composites having improved penetration resistance and articles fabricated from same
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2084560B1 (es) * 1994-03-09 1997-01-16 Almirall Lab Procedimiento de preparacion de derivados el indol.
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
EP2666772B1 (en) * 2002-12-20 2017-03-01 Basf Se Synthesis of amines and intermediates for the synthesis thereof
AU2008214205B2 (en) * 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
JP5164972B2 (ja) 2007-03-29 2013-03-21 第一三共株式会社 ｃＰＬＡ２阻害活性を有するインドール誘導体およびその用途並びに製造方法
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
AU2012287120B2 (en) 2011-07-22 2017-02-23 The University Of Chicago Treatments for migraine and related disorders
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
JPS5764669A (en) 1982-04-19
ES520783A0 (es) 1985-05-01
SE8104781L (sv) 1982-02-13
ES520784A0 (es) 1984-11-01
ES504693A0 (es) 1982-12-01
FR2488607A1 (fr) 1982-02-19
NL8103769A (nl) 1982-03-01
ES8500903A1 (es) 1984-11-01
CA1169428A (en) 1984-06-19
DE3131728C2 (es) 1992-04-30
DE3131728A1 (de) 1982-03-11
IT1171449B (it) 1987-06-10
DK157920C (da) 1990-08-06
IE51491B1 (en) 1987-01-07
ZA815540B (en) 1983-03-30
DK157920B (da) 1990-03-05
IE811830L (en) 1982-02-12
DK357081A (da) 1982-02-13
ES8500902A1 (es) 1984-11-01
IT8149084A0 (it) 1981-08-11
CH651551A5 (fr) 1985-09-30
SE454880B (sv) 1988-06-06
US4650810A (en) 1987-03-17
NZ197996A (en) 1985-08-16
ES8402268A1 (es) 1984-01-16
ES520785A0 (es) 1984-11-01
ES8301210A1 (es) 1982-12-01
AU7399481A (en) 1982-02-18
ES8504706A1 (es) 1985-05-01
FR2488607B1 (es) 1984-11-16
AU548467B2 (en) 1985-12-12
JPH0247462B2 (es) 1990-10-19
BE889929A (fr) 1982-02-11

Similar Documents

Publication Publication Date Title
ES504695A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES520784A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES501766A0 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
ES529802A0 (es) Un procedimiento para la preparacion de derivados del indol
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES516472A0 (es) Un procedimiento para la preparacion de derivados de 2-fenileta-nolamina.
ES503790A0 (es) Un procedimiento para la preparacion de una composicion de derivados del imidazor.
ES513934A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES507960A0 (es) Un procedimiento para la mejoracion de 3-(pirid-3-0,4-ilalquil)indoles
ES519057A0 (es) Un procedimiento para la preparacion de derivados de caprolactama.
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES513765A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES514039A0 (es) Un procedimiento para la preparacion de indol sulfonilureas.
ES507755A0 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES504790A0 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES513130A0 (es) Un procedimiento para la preparacion de nuevos derivados del indeno.
ES507015A0 (es) Procedimiento para la preparacion de nuevas indolinonas.
ES507034A0 (es) Un procedimiento para la preparacion de derivados tetrasubs-tituidos del benceno.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.
ES507918A0 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19901025